Janney Montgomery Scott’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
591,425
+142,756
| +32% | +$2.49M | 0.03% | 552 |
|
|
2025
Q1 | $5.64M | Buy |
448,669
+421,511
| +1,552% | +$5.3M | 0.02% | 731 |
|
|
2024
Q4 | $287K | Sell |
27,158
-2,000
| -7% | -$21.1K | ﹤0.01% | 2338 |
|
|
2024
Q3 | $423K | Buy |
29,158
+4,672
| +19% | +$67.8K | ﹤0.01% | 2079 |
|
|
2024
Q2 | $208K | Hold |
24,486
| – | – | ﹤0.01% | 2431 |
|
|
2024
Q1 | $250K | Buy |
24,486
+881
| +4% | +$9K | ﹤0.01% | 2445 |
|
|
2023
Q4 | $129K | Sell |
23,605
-467
| -2% | -$2.55K | ﹤0.01% | 2529 |
|
|
2023
Q3 | $91K | Sell |
24,072
-15,897
| -40% | -$60.1K | ﹤0.01% | 2485 |
|
|
2023
Q2 | $268K | Sell |
39,969
-10,274
| -20% | -$68.9K | ﹤0.01% | 2298 |
|
|
2023
Q1 | $327K | Sell |
50,243
-3,471
| -6% | -$22.6K | ﹤0.01% | 1998 |
|
|
2022
Q4 | $458K | Sell |
53,714
-28,319
| -35% | -$241K | ﹤0.01% | 1835 |
|
|
2022
Q3 | $433K | Sell |
82,033
-6,425
| -7% | -$33.9K | ﹤0.01% | 1791 |
|
|
2022
Q2 | $379K | Buy |
88,458
+3,892
| +5% | +$16.7K | ﹤0.01% | 1766 |
|
|
2022
Q1 | $297K | Sell |
84,566
-165
| -0.2% | -$579 | ﹤0.01% | 1889 |
|
|
2021
Q4 | $564K | Buy |
84,731
+69,203
| +446% | +$461K | ﹤0.01% | 1642 |
|
|
2021
Q3 | $155K | Sell |
15,528
-580
| -4% | -$5.79K | ﹤0.01% | 2198 |
|
|
2021
Q2 | $498K | Buy |
16,108
+248
| +2% | +$7.67K | ﹤0.01% | 1638 |
|
|
2021
Q1 | $692K | Buy |
15,860
+4,903
| +45% | +$214K | ﹤0.01% | 1388 |
|
|
2020
Q4 | $508K | Buy |
+10,957
| New | +$508K | ﹤0.01% | 1561 |
|